P

Palisade Bio
D

PALI

1.41000
USD
-0.13
(-8.14%)
Post Trading·1.44000USD+0.03000(+2.13%)
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
89,557
الربح لكل سهم
-0
العائد الربحي
-
P/E
2
حجم السوق
245,721,487

العنوان: Palisade Bio

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.